Nutrition 72 , 110659 (2020)
Of note, intra-follicular endocrine dysregulation is a plausible convergence layer for heterogeneous clinical phenotypes (e.g., endometriosis-, PCOS-, or age-associated follicular dysfunction), making it a rational target for integration rather than treating serum hormones as interchangeable proxies for the follicular milieu [255, 256]
While some peptides have undergone rigorous testing and are approved by the Food and Drug Administration (FDA), like GLP1s and Tesamorelin for specific medical conditions, a significant number of others have not been evaluated
It also supports cellular energy production, helping in overall vitality and wellness
10.1002/iub.2020 70 SpringettG